BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2001

View Archived Issues

Bakuchiol has in vitro antimicrobial activity against oral pathogens

Read More

Past exposure to vaccines may reduce risk of Alzheimer's disease

Read More

Transition Therapeutics acquires intellectual property to methyldonor technology for MS

Read More

Garlic supplements shown to interfere with HIV medication

Read More

Endovasc's NRA moves towards clinical development

Read More

Genaissance and AstraZeneca sign genomics agreement

Read More

Atugen and Oxford GlycoSciences collaborate on target validation

Read More

Genzyme and Pharming reach agreement

Read More

Discovery and Quintiles form Surfaxin sales and marketing alliance

Read More

Pexelizumab collaboration reviewed; 5G1.1 progress updated

Read More

Enrollment ahead of schedule in ISAtx-247 phase II psoriasis trial

Read More

Adolor receives three SBIR grants for pain relief research

Read More

Genaera identifies and targets novel gene in asthma

Read More

Antiangiogenic agent SU-6668/TSU-68 particularly effective against breast cancer

Read More

Mechanism of SAANDs confirmed in breast cancer cells

Read More

New therapeutic option available to leukemia patients in the U.K.

Read More

CDRI-93/478: preclinical compound for hypertension and myocardial ischemia

Read More

FR-226807, a highly potent and selective PDE5 inhibitor, compares favorably with sildenafil

Read More

TRAIL active against primary CLL and WSU-CLL alone and in combination with chemotherapeutic agents

Read More

New malaria vaccine offers significant protection against Plasmodium falciparum

Read More

First small-molecule cancer targets selected from BMS-Exelixis collaboration

Read More

Potent DP receptor antagonists claimed by Merck Frosst for allergic conditions

Read More

Roche spin-off company patents new triazole antifungal agents

Read More

Aminophenoxyacetamides with neuroprotective properties synthesized at Suntory

Read More

Inhibitors of NHE-3 designed by Merck KGaA

Read More

Preparation and use of nonpeptide MetAP2 inhibitors reported by GSK

Read More

Potent and selective inhibitors of thrombin disclosed by Corvas in recent patent

Read More

Distinctive endocrine profile of abarelix compared with LHRH agonists in prostate cancer

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 23, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing